LungLB in Subjects Presenting With Indeterminate Pulmonary Nodules

Status unconfirmed

Conditions studied: Solitary Pulmonary Nodule, Multiple Pulmonary Nodules

In brief

Correlate performance of LungLB Test with outcome of a scheduled biopsy.

Key facts

Study ID

NCT05171491

Run by

LungLife AI

People needed

425

Starts

2022-01-26

Expected to finish

2024-09-02

Last updated by the study team

2024-06-13

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• At least 18 years old with a CT identified indeterminate pulmonary nodule and scheduled for biopsy, at the time of consent.
• Planned biopsy nodule of interest:
• is solid ≤3 cm; or
• is nonsolid, ground glass opacity, of any size; or
• is part solid, where the solid component is no larger than 3cm (maximum diameter).

You may not qualify if…

• Current and or prior diagnosis +/- treatment of non-lung cancer within the past 3 years.
• Current and or prior lung cancer diagnosis within 2 years following intent-to-cure surgery.

Where it is running

• Clinical Site 04 — Los Angeles, California, United States
• Clinical Site 05 — Bay Pines, Florida, United States
• Clinical Site 03 — Miami, Florida, United States
• Clinical Site 07 — Hines, Illinois, United States
• Clinical Site 27 — Kansas City, Kansas, United States
• Clinical Site 12 — Wichita, Kansas, United States
• Clinical Site 08 — Kansas City, Missouri, United States
• Clinical Site 18 — Reno, Nevada, United States
• Clinical Site 01 — New York, New York, United States
• Clinical Site 25 — Columbia, South Carolina, United States
• Clinical Site 02 — Houston, Texas, United States
• Clinical Site 32 — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.